Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Immunization Schedules of Sabin IPV and bOPV
NCT04054492Phase 4Completed
- Sponsor
- China National Biotec Group
- Start
- Mar 2018
- Primary completion
- Jan 2019
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Inactivated poliovirus vaccine (Sabin strain), bivalent oral poliovirus vaccine in poliomyelitis, sponsored by China National Biotec Group. Started Mar 2018; status: completed.
02
Drugs
Inactivated poliovirus vaccine (Sabin strain)bivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT04054492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04054492.